Predice Score Sebagai Prediktor Mortalitas 90 Hari Pada Pasien Gagal Jantung

40

DAFTAR PUSTAKA

1. Panggabean M. Gagal Jantung. PD UI 2014, Edisi VI , Bab 18, hal 1132-35
2. Mann D, Chakinala M. Heart failure: Pathopysiology and diagnosis.
Harrison’s Principle of Internal Medicine 19th Ed. 2015.1500-1506
3. Johnson F. Pathophysiology and etiology of heart failure. Cardiol Clin 2014;
32: 9–19
4. Yancy C, Jessup M, Bozkurt B, Butler J, Casey D, Drazner M dkk. 2013
ACCF/AHA Guideline for the Management of Heart Failure A Report of the
American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. Circulation 2013; 128:e240-e327
5. Situasi Kesehatan Jantung. Pusat Data dan Informasi Kementrian Kesehatan
RI. 2014
6. Greene S, Fonarow G, Vaduganathan M, Khan S, Butler J, Gheorgidae M.
The vulnerable phase after hospitalization for heart failure. Nature reviews
cardiology 2015; 14:1-10
7. Metra M, Gheorghiade M, Bono R, Dei Cas L. Post Discharge Assessment
After a Heart Failure Hospitalization. The Next Step Forward. Circulation.
2010; 122: 1782-1785

8. Velavan P, Khan NK, Goode K, Rigby AS, Loh PH, Komajda M et al.
Predictors of short term mortality in heart failure - insights from the Euro
Heart Failure survey. International Journal of Cardiology 2010; 138: 63–69
9. Maisel A, Xue Y, Shah K, Mueller C, Nowark R, Peacock W et al. Increased
90-Day Mortality in Patients With Acute Heart Failure With Elevated
Copeptin Secondary Results From the Biomarkers in Acute Heart Failure
(BACH) Study. Circ Heart Fail. 2011;4:613-620
10. Scrutinio D, Amiratti E, Passantino A, Guida P, D’Angelo L, Olivia F et al.
Predicting Short Term Mortality in Advanced Decompensated Heart Failure.
Role of the Updated Acute Decompensated Heart Failure/N-Terminal Pro-BType Natriuretic Peptide Risk Score.Circulation journal 2015; 79. 1076 - 1083

Universitas Sumatera Utara

41

11. Camara A, Vales J, Tapia P, Esteban E, Fernandez del Pozo S, Sandubete E et al.
Role of biological and non biological factors in congestive heart failure mortality:
PREDICE Score: A clinical prediction rule. Cardiology Journal 2012;19: 578–585
12. Dunlay S, Manemann S, Chamberlain A, Cheville A, Jiang R, Weston S dkk.
Activities of Daily Living and Outcomes in Heart Failure. Circ Heart Fail 2015;25

13. Mozaffarian D, Go AS, Benjamin E, Roger VL, Berry J, Borden W et al.
Heart disease and stroke statistics 2013 update: a report from the American
Heart Association. Circulation 2013; 127: e6–245.
14. Roger VL, Weston SA, Redfield MM, Homan J, Killian J, Yawn B et al.
Trends in heart failure incidence and survival in a community-based
population. JAMA. 2004; 292: 344–50.
15. Levy D, Kenchaiah S, Larson MG, Benjamin E, Kupka M, Ho K et al. Longterm trends in the incidence of and survival with heart failure. N Engl J Med.
2002; 347: 1397–402.
16. Loehr LR, Rosamond WD, Chang PP, Folsom A, Chambless L. Heart failure
incidence and survival (from the Atherosclerosis Risk in Communities study).
Am J Cardiol. 2008;101:1016–22.
17. Jackson G, Gibbs C, Davies M, Lip G. ABC of heart failure pathophysiology.
BMJ 2000; 320:167 – 170
18. Bueno H, Ross JS, Wang Y, Chen J, Vidan M, Normand SL et al. Trends in
length of stay and short-term out- comes among Medicare patients
hospitalized for heart failure, 1993–2006. JAMA. 2010;303:2141–7.
19. Macintyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A et al.
Evidence of improving prognosis in heart failure: trends in case fatality in 66 547
patients hospitalized between 1986 and 1995. Circulation. 2000; 102:1126–1131.
20. Chugh S, Reinier K, Teodorescu C, Evanado A, Kehr E, Al Samara M et al.

Epidemiology of sudden cardiac death: clinical and research implications.
Prog Cardiovasc Dis. 2008;51:213–228.
21. Lloyd-Jones D, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB
et al. Heart disease and stroke statistics 2010 update: a report from the
American Heart Association. Circulation 2010;121:e46–e215.

Universitas Sumatera Utara

42

22. Ho K, Pnsky J, Kanel W, Levy D. The epidemiology of heart failure: The
Framingham Study. J Am Coll Cardiol. 1993;22(4s1):A6-A13
23. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term
survival after heart failure: a contemporary population-based perspective.
Arch Intern Med 2007;167:490–496
24. Velavan A, Khan N, Goode K, Rigby A, Loh P. Predictors of short term
mortality in heart failure - Insights from the Euro Heart Failure survey. Int J
Cardiol. 2010 Jan 7;138(1):63-69
25. Dharmarajan K, Hasieh A, Lin Z, Bueno H, Ross J, Horwitz L et al.
Diagnoses and timing of 30-day readmissions after hospitalization for heart

failure, acute myocardial infarction, or pneumonia. JAMA 2013;309:355–363.
26. Desai, A. S. & Stevenson, L. W. Rehospitalization for heart failure: predict or
prevent? Circulation 126, 501–506 (2012).
27. Chun, S. Tu J, Wijeysundera H, Austin P, Wang S, Levy D. et al. Lifetime
analysis of hospitalizations and survival of patients newly admitted with heart
failure. Circ. Heart Fail 2012; 5: 414–421
28. Gheorghiade M, Pang P, Ambrosy A, Lan G, Schmidt P, Fillipato G et al. A
comprehensive, longitudinal description of the in-hospital and post-discharge
clinical, laboratory, and neurohormonal course of patients with heart failure
who die or are re-hospitalized within 90 days: analysis from the EVEREST
trial. Heart Fail. Rev 2012; 17, 485–509.
29. Zile, MR, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT et
al. Transition from chronic compensated to acute decompensated heart failure:
pathophysiological insights obtained from continuous monitoring of
intracardiac pressures. Circulation 2008;118, 1433–1441.
30. Adamson PB, Magalski A, Braunscweight F, Bohm M, Reynolds D, Steinhasu D
et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of
measurements derived from an implantable monitoring system. J. Am. Coll.
Cardiol. 2003;41, 565–571.
31. Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL. Death in heart

failure: a community perspective. Circ Heart Fail. 2008;1:91–97.

Universitas Sumatera Utara

43

32. North B, Sinclair D. The intersection between aging and cardiovascular
disease. Circ Res. 2012;110:1097-1108.
33. Lakatta E, Levy D. Arterial and cardiac aging: major shareholders in
cardiovascular disease enterprises, part I: aging arteries: a “set up” for
vascular disease. Circulation. 2003;107:139 –146.
34. Strait J, Lakatta E. Aging associated cardiovascular changes and their relation
to heart failure. Heart Fail Clin. 2012; 8(1): 143–164
35. Gustafsson F, Pedersen C, Seibæk M, Burchardt H, Kober L for the
DIAMOND study group. Effect of age on short and long-term mortality in
patients admitted to hospital with congestive heart failure. European Heart
Journal 2004; 25, 1711–17
36. Suwaidi J, Asaad N, Al-Qahtani A, El-Menyar A, Al-Mulla A, Singh R et al.
Effect of Age on Outcome on Patients Hospitalized With Heart Failure: From
a 20-Year Registry in a Middle-Eastern Country (1991–2010). Congest Heart

Fail. 2012;18:320–326
37. Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors A.The role of the
kidney in heart failure. European Heart Journal 2012; 33, 2135–2143
38. Hillege H, Girbes A, de Kam P, Boomsma F. Renal Function, Neurohormonal
Activation, and Survival in Patients With Chronic Heart Failure. Circulation.
2000;102:203-210
39. Shamagian L, Román A, Pérez M, Otero I, Lamela A, Juanatey J. Renal
Failure Is an Independent Predictor of Mortality in Hospitalized Heart Failure
Patients and Is Associated With a Worse Cardiovascular Risk Profile. Rev Esp
Cardiol. 2006;59(2):99-108
40. Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646-659
41. Martínez-Sellés M, García Robles JA, Prieto L et al Hospitalized Congestive
Heart Failure Patients with Preserved versus Abnormal Left Ventricular
Systolic Function. Rev Esp Cardiol, 2002; 55: 579–586.
42. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting
mortality among patients hospitalized for heart failure: derivation and
validation of clinical model. JAMA, 2003; 290: 2581–2587.

Universitas Sumatera Utara


44

43. Hillege HL, Nitsch D, Pfeffer M et al.; Candesartan in Heart Failure:
Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators.
Renal function as a predictor of outcomes in a broad spectrum of patients with
heart failure. Circu- lation, 2006; 113: 671–678.
44. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf SA. A
multivariate model for predicting mortality in patients with heart failure and
systolic dysfunction. Am J Med, 2004; 116: 300–304.
45. Rusinaru D, Tribouilloy C, Berry C, Whalley G, Earle N, Poppe K dkk.
Relationship of serum sodium concentration to mortality in a wide spectrum
of heart failure patients with preserved and with reduced ejection fraction: an
individual patient data meta-analysis. Meta-Analysis Global Group in Chronic
heart failure (MAGGIC). European Journal of Heart Failure 2012;14, 1139 46
46. Filippatos T, Elisaf M. Hyponatremia in patients with heart failure. World J
Cardiol 2013; 5(9): 317-328
47. Rozzini R, Sabatini T, Cassinadri A, Boffelli S, Ferri M, Piera Barbisoni P
dkk. Relationship Between Functional Loss Before Hospital Admission and
Mortality in Elderly Persons With Medical Illness. Journal of Gerontology:
Medical Sciences 2005;60A: 1180–83

48. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State
Med J, 1965; 14: 61–65.

Universitas Sumatera Utara